Advisory Commission on Childhood Vaccines; Notice of Meeting, 9030 [2011-3527]
Download as PDF
<![CDATA[
9030
Federal Register / Vol. 76, No. 32 / Wednesday, February 16, 2011 / Notices
Number of
respondents
Application
Responses
per
respondent
Total
responses
Hours per
response
Total burden
hours
Waiver Request ...................................................................
10
1
10
6.5
65
Total ..............................................................................
10
1
10
6.5
65
E-mail comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–33,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 30 days of
this notice.
Dated: February 10, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–3528 Filed 2–15–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
mstockstill on DSKH9S0YB1PROD with NOTICES
Advisory Commission on Childhood
Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date And Time: March 3, 2011, 9 a.m.
to 5 p.m. EDT, March 4, 2011, 9 a.m. to
12 p.m. EDT.
Place: Parklawn Building (and via
audio conference call), Conference
Rooms G & H, 5600 Fishers Lane,
Rockville, MD 20857.
The ACCV will meet on Thursday,
March 3 from 9 a.m. to 5 p.m. (EDT) and
on Friday, March 4 from 9 a.m. to 12
p.m. (EDT). The public can join the
meeting via audio conference call by
dialing 1–800–369–3104 on March 3
and March 4 and providing the
following information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the
March meeting will include, but are not
limited to: updates from the Division of
Vaccine Injury Compensation (DVIC),
Department of Justice (DOJ), National
Vaccine Program Office, Immunization
Safety Office (Centers for Disease
Control and Prevention), National
Institute of Allergy and Infectious
Diseases (National Institutes of Health),
Center for Biologics, Evaluation and
Research (Food and Drug
Administration), a discussion on the
VICP outreach efforts, and a review of
VerDate Mar<15>2010
17:10 Feb 15, 2011
Jkt 223001
Vaccine Information Statements (VISs).
A draft agenda and additional meeting
materials will be posted on the ACCV
Web site (https://www.hrsa.gov/
vaccinecompensation/accv.htm) prior to
the meeting. Agenda items are subject to
change as priorities dictate.
Public Comment: Persons interested
in providing an oral presentation should
submit a written request, along with a
copy of their presentation to: Annie
Herzog, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and
Services Administration (HRSA), Room
11C–26, 5600 Fishers Lane, Rockville,
Maryland 20857 or e-mail:
aherzog@hrsa.gov. Requests should
contain the name, address, telephone
number, e-mail address, and any
business or professional affiliation of
the person desiring to make an oral
presentation. Groups having similar
interests are requested to combine their
comments and present them through a
single representative. The allocation of
time may be adjusted to accommodate
the level of expressed interest. DVIC
will notify each presenter by e-mail,
mail or telephone of their assigned
presentation time. Persons who do not
file an advance request for a
presentation, but desire to make an oral
statement, may announce it at the time
of the comment period. Public
participation and ability to comment
will be limited to space and time as it
permits.
FOR FURTHER INFORMATION CONTACT:
Anyone requiring information regarding
the ACCV should contact Annie Herzog,
DVIC, HSB, HRSA, Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857;
telephone (301) 443–6593 or e-mail:
aherzog@hrsa.gov.
Dated: February 10, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–3527 Filed 2–15–11; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials (R01).
Date: March 10, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: James T. Snyder, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities/
NIAID, National Institutes of Health, 6700B
Rockledge Drive, MSC 7616, Room #3257,
Bethesda, MD 20892–7616, 301–435–1614,
james.snyder@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Genetics of Lupus.
Date: March 11, 2011.
Time: 11:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, 3136, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Wendy F. Davidson, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–402–
8399, davidsonw@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
E:\FR\FM\16FEN1.SGM
16FEN1
]]>Agencies
[Federal Register Volume 76, Number 32 (Wednesday, February 16, 2011)]
[Notices]
[Page 9030]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3527]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), notice is hereby given of the
following meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date And Time: March 3, 2011, 9 a.m. to 5 p.m. EDT, March 4, 2011,
9 a.m. to 12 p.m. EDT.
Place: Parklawn Building (and via audio conference call),
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, March 3 from 9 a.m. to 5 p.m. (EDT)
and on Friday, March 4 from 9 a.m. to 12 p.m. (EDT). The public can
join the meeting via audio conference call by dialing 1-800-369-3104 on
March 3 and March 4 and providing the following information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the March meeting will include, but
are not limited to: updates from the Division of Vaccine Injury
Compensation (DVIC), Department of Justice (DOJ), National Vaccine
Program Office, Immunization Safety Office (Centers for Disease Control
and Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health), Center for Biologics, Evaluation and
Research (Food and Drug Administration), a discussion on the VICP
outreach efforts, and a review of Vaccine Information Statements
(VISs). A draft agenda and additional meeting materials will be posted
on the ACCV Web site (https://www.hrsa.gov/vaccinecompensation/accv.htm)
prior to the meeting. Agenda items are subject to change as priorities
dictate.
Public Comment: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail:
aherzog@hrsa.gov. Requests should contain the name, address, telephone
number, e-mail address, and any business or professional affiliation of
the person desiring to make an oral presentation. Groups having similar
interests are requested to combine their comments and present them
through a single representative. The allocation of time may be adjusted
to accommodate the level of expressed interest. DVIC will notify each
presenter by e-mail, mail or telephone of their assigned presentation
time. Persons who do not file an advance request for a presentation,
but desire to make an oral statement, may announce it at the time of
the comment period. Public participation and ability to comment will be
limited to space and time as it permits.
FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding
the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C-26,
5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-6593 or e-
mail: aherzog@hrsa.gov.
Dated: February 10, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-3527 Filed 2-15-11; 8:45 am]
BILLING CODE 4165-15-P
